US Broker Ratings

RadNet, Inc. (RDNT) Stock Analysis: Unpacking a 32% Upside Potential Amid Healthcare Expansion

RadNet, Inc. (NASDAQ: RDNT), a pivotal player in the Healthcare sector and specialized in the Diagnostics & Research industry, is capturing investor attention with its remarkable growth potential. With a..

BrightSpring Health Services (BTSG) Rating Update: 16 Buy Ratings Signal Strong Growth Potential

BrightSpring Health Services, Inc. (BTSG) stands out in the healthcare sector, delivering robust growth and attracting significant investor interest. With a market capitalization of $7.16 billion, this U.S.-based company is..

Genmab A/S (GMAB) Stock Analysis: Biotechnology Giant Poised for 22.75% Upside with Strong Buy Ratings

Investors eyeing the healthcare sector often turn their attention to Genmab A/S (NASDAQ: GMAB), a leading biotechnology company headquartered in Copenhagen, Denmark. With a robust market capitalization of $19.03 billion,..

Revvity, Inc. (RVTY) Stock Analysis: A Potential 17.69% Upside in the Healthcare Diagnostics Sector

For investors with an interest in the healthcare sector, Revvity, Inc. (NYSE: RVTY) presents a compelling opportunity. With a market capitalization of $11.79 billion, this U.S.-based company operates in the..

BioNTech SE (BNTX) Stock Analysis: A 31.79% Upside Potential Amidst Promising Clinical Trials

BioNTech SE (NASDAQ: BNTX), a leading player in the biotechnology sector, has been making waves in the healthcare industry with its cutting-edge immunotherapies targeting cancer and infectious diseases. Headquartered in..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a 53.95% Potential Upside

TG Therapeutics, Inc. (NASDAQ: TGTX) is making waves in the biotechnology sector with its innovative approach to treating B-cell mediated diseases. As a commercial-stage biopharmaceutical company, TG Therapeutics is not..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: A 169.50% Potential Upside Amid Clinical Advancements

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is generating considerable buzz in the healthcare sector with its promising stock potential. As a clinical-stage biopharmaceutical company, Soleno is dedicated to developing novel treatments..

Avantor, Inc. (AVTR)

⚠️ No article content returned.

..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating the Healthcare Sector with a 28.90% Upside Potential

Oscar Health, Inc. (NYSE: OSCR) is carving out its niche in the competitive healthcare sector. As a technology-driven healthcare company, Oscar Health offers an array of services, including health plans..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Navigating Growth with a 2.72% Upside Potential

Dr. Reddy’s Laboratories Ltd (NYSE: RDY) continues to be a significant player in the global healthcare sector, primarily within the drug manufacturing industry for specialty and generic products. Headquartered in..

Encompass Health Corporation (EHC) Stock Analysis: Uncovering a 35% Upside Potential

Encompass Health Corporation (NYSE: EHC) is a prominent player in the healthcare sector, specializing in post-acute care services. With a market capitalization of $10.6 billion, this Birmingham, Alabama-based company is..

Fresenius Medical Care AG (FMS) Stock Analysis: Evaluating a 17% Potential Upside in Healthcare

Fresenius Medical Care AG (NYSE: FMS), a prominent player in the healthcare sector, specifically in the medical care facilities industry, presents a compelling narrative for investors with a 17.15% potential..

Alkermes plc (ALKS) Stock Analysis: Why Investors Should Consider the 25.5% Upside Potential

Alkermes plc (NASDAQ: ALKS) is capturing the attention of investors with its noteworthy potential for growth. As a prominent player in the healthcare sector, specifically in the specialty and generic..

Avidity Biosciences, Inc. (RNA) Stock Analysis: Exploring Growth Potential Amidst 434% Revenue Surge

For investors seeking opportunities within the healthcare sector, Avidity Biosciences, Inc. (NASDAQ: RNA) presents a fascinating case. This biopharmaceutical company, headquartered in San Diego, California, specializes in RNA therapeutics, specifically..

Masimo Corporation (MASI) Stock Analysis: Analyzing the 32% Potential Upside

Masimo Corporation (MASI), a leader in the healthcare sector specializing in innovative medical devices, is drawing significant attention from investors due to a potential upside of 32.05%. With a current..

Teleflex Incorporated (TFX) Investor Outlook: Analyzing a 19.21% Potential Upside for This Medical Device Innovator

Teleflex Incorporated (NYSE: TFX) stands as a notable player in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $4.79 billion, Teleflex is..

Insmed Incorporated (INSM) Stock Analysis: A 43.57% Upside Potential in Biotechnology

Insmed Incorporated (NASDAQ: INSM), a prominent player in the biotechnology sector, is currently attracting attention from investors with its impressive market cap of $31.96 billion. Specializing in therapies for serious..

Tempus AI, Inc. (TEM) Stock Analysis: Healthcare Innovator with 60% Upside Potential

Tempus AI, Inc. (NASDAQ: TEM), a prominent player in the healthcare technology sector, has captured investor attention with its innovative approach to health information services. With a market capitalization of..

Natera, Inc. (NTRA) Investor Outlook: Navigating Growth with a 26.67% Upside Potential

Natera, Inc. (NASDAQ: NTRA), a notable name in the healthcare sector, specializes in diagnostics and research, offering cutting-edge molecular testing services. With a market capitalization of $28.31 billion, Natera stands..

Repligen Corporation (RGEN): Investor Outlook on a 34% Potential Upside Amidst Robust Revenue Growth

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, particularly in the medical instruments and supplies industry, is attracting attention from investors for its promising growth outlook. Headquartered..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds